ClinicalTrials.Veeva

Menu

Italian Version of the Modified Barthel Index

D

Don Carlo Gnocchi Onlus Foundation

Status

Not yet enrolling

Conditions

Validation Study
Reliability and Validity
Cross-Cultural Comparison
Disability Physical

Study type

Observational

Funder types

Other

Identifiers

NCT05831215
mBI - MI - part B

Details and patient eligibility

About

This study aims to develop and validate the Italian version of the modified Barthel Index (mBI-Italian), through the following steps:

  • translation of the mBI into Italian, by using the froward-backward translation approach, to produce a pre-final mBI-Italian
  • pre-pilot testing of the pre-final mBI-Italian in a sample of ten health professionals (physicians and physiotherapists), ten subjects who had a stroke, and 10 caregivers, i.e. subjects who take care of a person who had a stroke. All participants will be asked to judge the clarity of each item of the scale, including scoring instructions
  • evaluation of the metric properties (internal consistency, inter- and intra-rater reliability, validity and responsiveness) of the final mBI-Italian in a sample of subjects admitted to the Don Gnocchi Foundation in Florence for rehabilitation after stroke

Full description

The modified Barthel Index (mBI) (Shah et al (1989) is a worldwide adopted scale which investigates independence in the basic activities of daily living. It comprises ten items as the original version (personal hygiene, bathing, feeding, toilet, stairs, dressing, bowels, bladder, transfers, ambulation/wheelchair management), with a modification to the scoring to enhance its responsiveness. The mBI has been cross-culturally adapted in several countries and languages, However, despite unofficial versions circulating in clinical settings, there is currently no validated Italian version of the scale. This study aims to develop this version and to evaluate its metric properties in a sample of subjects who had a stroke.

A pre-final mBI-Italian will be produced following established international guidelines (forward-backward translation, each step involving two different translators). This version will be tested in a group of ten health professionals (physicians and physiotherapists), ten subjects who had a stroke and ten caregivers, All participants will be asked to judge the clarity of each item of the scale, including scoring instructions, using a dichotomous response (clear/unclear). Items that are judged unclear by more than 20 percent of evaluators will be revised by the multidisciplinary translation team to produce the final mBI-Italian.

The final mBI-Italian will then be administered to a sample of at least 100 subjects with stroke to assess its metric properties in this population. Participants will be enrolled among patients admitted to the Don Gnocchi Foundation in Florence for stroke rehabilitation. To assess reliability, upon admission each patient will be independently assessed using the mBI-Italian by two examiners, drawn at random from a group of ten physiotherapists. One of the two raters will administer the scale twice on consecutive days. Other evaluators will administer other clinical scales (Fugl-Meyer assessment, FMA; modified Rankin scale, mRS) to assess the validity of the mBI-Italian. All raters will be blinded to all other assessments and to their previous assessment, if any. All the scales will be administered again at discharge, when participants will also be asked to indicate the perceived change since admission in their ability to autonomously manage the basic activities of daily living (ADLs). For the latter, a 7-points Global Rating of Perceived Change (GRPC) Lickert scale will be used.

The Cronbach's alpha will be used to estimate the internal consistency of the scale. To assess intra-rater and inter-rater reliability, the Intraclass Correlation Coefficient (ICC1,1), Standard Error of the Measurement (SEM) and Minimal Detectable Change with 95% Confidence (MDC95) will be computed. Criterion and construct validity will be assessed by computing the association between the mBI-Italian and the FMA and the mRS, at both admission and discharge. For responsiveness, the following indices will be calculated: 1) Guyatt Responsiveness Index (GRI); 2) Standardized Response Mean (SMR), both in the whole sample and in subgroups of participants with different outcome (improved, unchanged, worsened) based on the GPRC; 3) Minimal Clinically Important Difference (MCID). The latter will be derived using the ROC curve approach, using the patient's perceived change in his/her autonomy in basic ADLs as an anchor.

Enrollment

145 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

The study is divided in two phases: A) pilot-testing of the pre-final mBI-Italian, and B) verification of the metric properties (reliability, validity and responsiveness) of the final mBI-Italian.

A) Pilot-test of the pre-final mBI-Italian (verification of clarity of all items):

Inclusion criteria:

Health professionals:

  • Being a physician or a physiotherapist with at least three
  • years of experience in the functional assessment of subjects with stroke;
  • willingness to participate in the study.

Subjects who had a stroke:

  • age 18 years or older
  • stroke outcomes such that they impact the person's ability to independently perform various basic activities of daily living
  • willingness to participate in the study, with informed consent signed (by the support administrator/legal guardian, if necessary)

Caregivers:

  • age 18 years or older;
  • Being a person who takes care of a disabled subject who had a stroke;
  • willingness to participate in the study,

Exclusion criteria:

Health professionals: none

Subjects who had a stroke:

  • severe visual and/or auditory impairment that cannot be corrected
  • cognitive impairment defined by a Mini Mental State Examination (MMSE) score <21;
  • severe language impairment such that comprehension and performance of the task is prevented
  • presence of signs of clinical instability, defined by a score greater than zero on the Clinical Instability Scale

Caregivers:

  • severe visual and/or auditory impairment that cannot be corrected
  • cognitive impairment defined by a Mini Mental State Examination (MMSE) score <21
  • severe language impairment such that comprehension and performance of the task is prevented.

B) Study on the metric properties of the final mBI-Italian:

  1. Participants (subjects who had a stroke): all patients consecutively admitted to the Don Gnocchi Foundation of Florence for rehabilitation after stroke (until the expected sample size is completed) who meet the following criteria.

    Inclusion criteria:

    • age 18 years or older
    • stroke outcomes such that they impact the person's
    • ability to independently perform various basic activities of daily living
    • willingness to participate in the study, with informed consent signed (by the support administrator/legal guardian, if necessary)

    Exclusion criteria:

    • severe visual and/or auditory impairment that cannot be corrected
    • cognitive impairment defined by a Mini Mental State Examination (MMSE) score <21
    • severe language impairment such that comprehension and performance of the task is prevented
    • presence of signs of clinical instability, defined by a score greater than zero on the Clinical Instability Scale
  2. Raters: ten physiotherapists with at least three years of experience in the evaluation and treatment of subjects with stroke outcomes. Pairs of raters, equal in number to the number of patients enrolled, will be randomly drawn from this group, and each pair will be randomly assigned to a patient to be administered the mBI-IT. Other examiners, also randomly drawn from the list of ten raters, will administer other clinical scales to participants to assess the validity of the mBI-IT.

Trial contacts and locations

0

Loading...

Central trial contact

Stefano Doronzio, MSc; Marco Baccini, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems